2024 Journal Article Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphomaMacManus, Michael P., Seymour, John F., Tsang, Hennes, Fisher, Richard, Keane, Colm, Sabdia, Muhammed B., Law, Soi C., Gunawardana, Jay, Nath, Karthik, Kazakoff, Stephen H., Marques-Piubelli, Mario L., Duenas, Daniela E., Green, Michael R., Roos, Daniel, O'Brien, Peter, McCann, Andrew, Tsang, Richard, Davis, Sidney, Christie, David, Cheah, Chan, Amanuel, Benhur, Cochrane, Tara, Butler, Jason, Johnston, Anna, Shanavas, Mohamed, Li, Li, Vajdic, Claire, Kridel, Robert, Shelton, Victoria ... Tobin, Joshua W.D. (2024). Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma. eBioMedicine, 110 105468, 105468. doi: 10.1016/j.ebiom.2024.105468 |
2024 Journal Article Outcomes for high-risk defining events in follicular lymphoma following frontline immunochemotherapyTobin, Joshua W. D., Chikatamarla, Venkata A., Matic, Marko, Griffin, Alison, Chowdhury, Rakin, Salvaris, Ross, Goh, Amanda, Black, Harrison, Tong, Tsz Hung, Birks, Callum, Jain, Sanjiv, Goodall, Elizabeth, Sirdesai, Shreerang, Trevis, Thomas, Steinepreis, Elizabeth, Chen, Yiyang, Li, Li, Broadby, Glenn, Gutta, Glenn, Morris, Kirk, Cochrane, Tara, Trotman, Judith, Talaulikar, Dipti, Shortt, Jake, Hodges, Georgina, Hawkes, Eliza, Cheah, Chan Y., Barraclough, Allison, Manos, Kate ... Hapgood, Greg (2024). Outcomes for high-risk defining events in follicular lymphoma following frontline immunochemotherapy. Blood Neoplasia, 1 (4) 100044, 1-9. doi: 10.1016/j.bneo.2024.100044 |
2024 Conference Publication Plasma Cell Enumeration By Manual and Automated Methods to Establish a Standard Pictorial ReferenceMurali, Aarya, Tobin, Joshua W.D. and Mollee, Peter (2024). Plasma Cell Enumeration By Manual and Automated Methods to Establish a Standard Pictorial Reference. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-204199 |
2024 Conference Publication Practices and Outcomes during a Watch and Wait Approach for Follicular Lymphoma: A Study from the Australasian Lymphoma AllianceBarge, Luani, Tobin, Joshua W.D., Waters, Niamh, Salvaris, Ross, Lai, Sam, Potezny, Tessa, Cashman, Helen, Nguyen-Ngo, Caitlyn, Lee, Denise, Yannakou, Costas K., Hamad, Nada, Tam, Constantine S., Bhattacharyya, Abir, Cheah, Chan Y., Morris, Kirk, Hawkes, Eliza A. and Hapgood, Greg (2024). Practices and Outcomes during a Watch and Wait Approach for Follicular Lymphoma: A Study from the Australasian Lymphoma Alliance. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-203146 |
2024 Journal Article Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapyHershenfeld, Samantha A., Tobin, Josuha W. D., Shelton, Victoria, Calvente, Lourdes, Lajkosz, Katherine, Liu, Ting, Brodtkorb, Marianne, d'Amore, Francesco Annibale, Ludvigsen, Maja, Baetz, Tara, LeBrun, David, Johnson, Nathalie, Crump, Michael, Hong, Michael, Kuruvilla, John, Tremblay-LeMay, Rosemarie, MacManus, Michael, Tsang, Richard, Hodgson, David C., Gandhi, Maher K. and Kridel, Robert (2024). Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapy. British Journal of Haematology, 205 (5), 1810-1814. doi: 10.1111/bjh.19698 |
2024 Journal Article Intra‐tumoral and peripheral blood <scp>TIGIT</scp> and <scp>PD</scp>‐1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphomaGunawardana, Jay, Law, Soi C., Sabdia, Muhammed B., Fennell, Éanna, Hennessy, Aoife, Leahy, Ciara I., Murray, Paul G., Bednarska, Karolina, Brosda, Sandra, Trotman, Judith, Berkahn, Leanne, Zaharia, Andreea, Birch, Simone, Burgess, Melinda, Talaulikar, Dipti, Lee, Justina N., Jude, Emily, Hawkes, Eliza A., Jain, Sanjiv, Nath, Karthik, Snell, Cameron, Swain, Fiona, Tobin, Joshua W. D., Keane, Colm, Shanavas, Mohamed, Blyth, Emily, Steidl, Christian, Savage, Kerry, Farinha, Pedro ... Gandhi, Maher K. (2024). Intra‐tumoral and peripheral blood TIGIT and PD‐1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma. American Journal of Hematology, 99 (11), 2096-2107. doi: 10.1002/ajh.27459 |
2024 Journal Article Identification of genetic subtypes in follicular lymphomaShelton, Victoria, Detroja, Rajesh, Liu, Ting, Isaev, Keren, Silva, Anjali, Passerini, Verena, Bakhtiari, Mehran, Calvente, Lourdes, Hong, Michael, He, Michael Y., Modi, Saloni, Hershenfeld, Samantha A., Ludvigsen, Maja, Madsen, Charlotte, Hamilton-Dutoit, Stephen, d’Amore, Francesco Annibale, Brodtkorb, Marianne, Johnson, Nathalie A., Baetz, Tara, LeBrun, David, Tobin, Josh W. D., Gandhi, Maher K., Mungall, Andrew J., Xu, Wei, Ben-Neriah, Susana, Steidl, Christian, Delabie, Jan, Tremblay-LeMay, Rosemarie, Jegede, Opeyemi ... Kridel, Robert (2024). Identification of genetic subtypes in follicular lymphoma. Blood Cancer Journal, 14 (1) 128, 128. doi: 10.1038/s41408-024-01111-w |
2024 Journal Article Diagnosis, management and follow‐up of follicular lymphoma: a consensus practice statement from the Australasian Lymphoma AllianceTobin, Joshua W. D., Hapgood, Greg, Johnston, Anna, Cheah, Chan Y., Lee, Sze T., Trotman, Judith, Inam, Shafqat, Campbell, Belinda A., Norris, Debbie, MacManus, Michael, Hertzberg, Mark and Hawkes, Eliza (2024). Diagnosis, management and follow‐up of follicular lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance. Internal Medicine Journal, 54 (8), 1384-1395. doi: 10.1111/imj.16454 |
2024 Journal Article Epstein–Barr virus‐associated lymphomas decodedBednarska, Karolina, Chowdhury, Rakin, Tobin, Joshua W. D., Swain, Fiona, Keane, Colm, Boyle, Stephen, Khanna, Rajiv and Gandhi, Maher K. (2024). Epstein–Barr virus‐associated lymphomas decoded. British Journal of Haematology, 204 (2), 415-433. doi: 10.1111/bjh.19255 |
2023 Conference Publication High Frequency of HLA-Class II B Cell Receptor Neoantigens in IGHV Mutated-CLLSabdia, Muhammed B., Burgess, Melinda, Law, Soi Cheng, Thurgood, Lauren A., Kazakoff, Stephen, Swain, Fiona, Tobin, Joshua W.D., Mollee, Peter, Patch, Ann-Marie and Gandhi, Maher K (2023). High Frequency of HLA-Class II B Cell Receptor Neoantigens in IGHV Mutated-CLL. 65th ASH Annual Meeting, San Diego, CA United States, 9-12 December 2023. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2023-174149 |
2023 Conference Publication The Nature of High-Risk Defining Events in Follicular Lymphoma Determines Overall SurvivalTobin, Joshua W.D., Chowdhury, Rakin, Salvaris, Ross, Griffin, Alison, Chikatamarla, Venkata, Goh, Amanda, Tong, Tsz Hung, Birks, Callum, Jain, Sanjiv, Goodall, Elizabeth, Sirdesai, Shreerang, Trevis, Thomas, Elizabeth, Steinepreis, Chen, Yiyang, Black, Harrison, Broadby, Glenn, Li, Li, Gutta, Naadir, Morris, Kirk Lachlan, Cochrane, Tara, Trotman, Judith, Talaulikar, Dipti, Shortt, Jake, Hodges, Georgina, Cheah, Chan Y., Barraclough, Allison A, Manos, Kate, Johnston, Anna M., Royle, Jane ... Hapgood, Greg (2023). The Nature of High-Risk Defining Events in Follicular Lymphoma Determines Overall Survival. 65th ASH Annual Meeting, San Diego, CA United States, 9-12 December 2023. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2023-185879 |
2023 Conference Publication Imaging cardiac amyloidosis using 18F-florbetaben positron electron topography (PET) in systemic light chain (AL) amyloidosisAnderson, Nirija Ranjit, Tobin, Joshua, Law, Phillip and Mollee, Peter (2023). Imaging cardiac amyloidosis using 18F-florbetaben positron electron topography (PET) in systemic light chain (AL) amyloidosis. International Myeloma Society 20th Annual Meeting and Exposition, Athens, Greece, 27-30 September 2023. New York, NY United States: Elsevier. doi: 10.1016/s2152-2650(23)02059-1 |
2023 Journal Article Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemiaCass, S. H., Tobin, J. W. D., Seo, Y. D., Gener-Ricos, G., Keung, E. Z., Burton, E. M., Davies, M. A., McQuade, J. L., Lazar, A. J., Mason, R., Millward, M., Sandhu, S., Khoo, C., Warburton, L., Guerra, V., Haydon, A., Dearden, H., Menzies, A. M., Carlino, M., Smith, J. L., Mollee, P., Burgess, M., Mapp, S., Keane, C., Atkinson, V., Parikh, S. A., Markovic, S. N., Ding, W., Call, T. G. ... Ferrajoli, A. (2023). Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia. Annals of Oncology, 34 (9), 796-805. doi: 10.1016/j.annonc.2023.06.007 |
2023 Conference Publication Prognostic impact of HLA‐I neoantigen‐specific CD8+ T cells in limited‐stage follicular lymphomaTobin, J. W., Tsang, H., Patch, A., Keane, C., Law, S. C., Gunawardana, J., Blombery, P., Thompson, E. R., Sabdia, M. B., De Long, L. M., Nath, K., Kazakoff, S. H., Cheah, C., Amanuel, B., Cochrane, T., Butler, J., Johnston, A., Shanavas, M., Li, L., Shelton, V., Hershenfeld, S., Kridel, R., Seymour, J. F., MacManus, M. and Gandhi, M. K. (2023). Prognostic impact of HLA‐I neoantigen‐specific CD8+ T cells in limited‐stage follicular lymphoma. 17th International Conference on Malignant Lymphoma, Lugano, Switzerland, 13 - 17 June 2023. Chichester, West Sussex United Kingdom: Wiley-Blackwell. doi: 10.1002/hon.3164_189 |
2023 Conference Publication Rituximab‐containing combined modality therapy in limited stage follicular lymphoma: mature follow up and derivation of a novel prognostic score from the TROG99.03 trialTobin, J. W., Jurinovic, V., Tsang, H., Roos, D., Tsang, R., Macann, A., Davis, S., Christie, D., Law, S., Nath, K., Sabdia, M., Patch, A. M., Gunawardana, J., Merida de Long, L., Hoster, E., Horn, H., Shanavas, M., Li, L., Cheah, C., Benhur, A., Hou, M., O'Brien, P., Johnston, A. M., Cochrane, T., Butler, J., Thompson, E., Blombery, P., Seymour, J. F., Gandhi, M. K. and MacManus, M. (2023). Rituximab‐containing combined modality therapy in limited stage follicular lymphoma: mature follow up and derivation of a novel prognostic score from the TROG99.03 trial. 17th International Conference on Malignant Lymphoma, Lugano, Switzerland, 13-17 June 2023. Oxford, United Kingdom: John Wiley & Sons. doi: 10.1002/hon.3163_140 |
2023 Conference Publication Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma (AM) in patients with concomitant chronic lymphocytic leukemia (CLL)Cass, Samuel, Tobin, Joshua, Seo, Yongwoo David, Gener-Ricos, Georgina, Keung, Emily Zhi-Yun, Burton, Elizabeth M., Walsh, Danielle M., Davies, Michael A., McQuade, Jennifer Leigh, Lazar, Alexander J., Hampel, Paul Joseph, Wargo, Jennifer Ann and Ferrajoli, Alessandra (2023). Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma (AM) in patients with concomitant chronic lymphocytic leukemia (CLL). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL USA, 2-6 June 2023. Philadelphia, PA USA: Lippincott Williams & Wilkins. |
2023 Journal Article Resolution of melanoma to PD-1 blockade but simultaneous rapid progression of concomitant chronic lymphocytic leukemiaBurgess, Melinda, Keane, Colm, Tobin, Joshua W. D., Law, Soi Cheng, Griffin, Alison, Gill, Devinder, Ewing, Adam D., Atkinson, Victoria, Mollee, Peter, Sabdia, Muhammed B., Saunders, Nicholas and Gandhi, Maher K. (2023). Resolution of melanoma to PD-1 blockade but simultaneous rapid progression of concomitant chronic lymphocytic leukemia. Acta Haematologica, 146 (2), 166-171. doi: 10.1159/000527631 |
2023 Journal Article Diffuse large B-cell lymphoma and red cell autoimmunity: clinical role and pathogenesisCoombes, Caitlin, Horikawa, Keisuke, Jain, Sanjiv, Jiang, Simon, Lim, Jun Hee, Saxena, Kartik, Shadbolt, Bruce, Smyth, Lillian, Tobin, Joshua and Talaulikar, Dipti (2023). Diffuse large B-cell lymphoma and red cell autoimmunity: clinical role and pathogenesis. Pathology, 55 (1), 104-112. doi: 10.1016/j.pathol.2022.07.017 |
2022 Conference Publication Identification of Genetic Subtypes in Follicular LymphomaShelton, Victoria, Isaev, Keren, Liu, Ting, Silva, Anjali, Detroja, Rajesh, Bakhtiari, Mehran, Calvente, Lourdes, Hong, Michael, Modi, Saloni, Hershenfeld, Samantha A., Ludvigsen, Maja, d'Amore, Francesco Annibale, Brodtkorb, Marianne, Johnson, Nathalie A., Baetz, Tara, LeBrun, David, Tobin, Josh, Gandhi, Maher K., Mungall, Andrew J., Steidl, Christian, Delabie, Jan, Tremblay-Lemay, Rosemarie, Kahl, Brad S., Evens, Andrew M and Kridel, Robert (2022). Identification of Genetic Subtypes in Follicular Lymphoma. 64th ASH Annual Meeting, New Orleans, LA United States, 10-13 December 2022. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2022-164610 |
2022 Journal Article Crebbp mutations are associated with shorter time to progression in limited-stage follicular lymphoma treated with radiationHershenfeld, Samantha A., Shelton, Victoria, Bakhtiari, Mehran, Calvente, Lourdes, Lajkosz, Katherine, Isaev, Keren, Silva, Anjali, Liu, Ting, Brodtkorb, Marianne, d'Amore, Francesco Annibale, Ludvigsen, Maja, Madsen, Charlotte, Hamilton-Dutoit, Stephen, Gandhi, Maher, Tobin, Joshua W.D., Baetz, Tara, LeBrun, David, Johnson, Nathalie A., Mungall, Andrew J., Crump, Michael, Delabie, Jan, Gospodarowicz, Mary, Hodgson, David, Hong, Michael, Kukreti, Vishal, Kuruvilla, John, Prica, Anca, Tremblay-Lemay, Rosemarie, Tsang, Richard and Kridel, Robert (2022). Crebbp mutations are associated with shorter time to progression in limited-stage follicular lymphoma treated with radiation. Blood, 140 (S1), 3532-3533. doi: 10.1182/blood-2022-156571 |